dapsone has been researched along with Hepatitis B, Chronic in 1 studies
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meissner, M | 1 |
| Beier, C | 1 |
| Gille, J | 1 |
| Kaufmann, R | 1 |
1 other study available for dapsone and Hepatitis B, Chronic
| Article | Year |
|---|---|
Annular leukocytoclastic vasculitis in association with chronic hepatitis B.
Topics: Aged; Antiviral Agents; Dapsone; Hepatitis B, Chronic; Humans; Lamivudine; Male; Treatment Outcome; | 2007 |